CN Patent
CN108653292B — 一种化合物在治疗或预防高原病中的用途
Assigned to Chinese PLA General Hospital · Expires 2019-05-24 · 7y expired
What this patent protects
本发明提供了一种具有通式I的化合物或其药学上可接受的盐在制备治疗高原病的药物组合物中的用途,所述的高原病选自在海拔2000m以上的高原环境下产生的急性高原病和慢性高原病。
USPTO Abstract
本发明提供了一种具有通式I的化合物或其药学上可接受的盐在制备治疗高原病的药物组合物中的用途,所述的高原病选自在海拔2000m以上的高原环境下产生的急性高原病和慢性高原病。
Drugs covered by this patent
- Opsumit (MACITENTAN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.